Back to Search Start Over

Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1.

Authors :
Mancinelli, Romina
Onori, Paolo
Gaudio, Eugenio
DeMorrow, Sharon
Franchitto, Antonio
Francis, Heather
Glaser, Shannon
Carpino, Guido
Venter, Julie
Alvaro, Domenico
Kopriva, Shelley
White, Mellanie
Kossie, Ashley
Savage, Jennifer
Alpini, Gianfranco
Source :
American Journal of Physiology: Gastrointestinal & Liver Physiology; Jul2009, Vol. 297, pG11-G26, 16p, 2 Charts, 7 Graphs
Publication Year :
2009

Abstract

Sex hormones regulate cholangiocyte hyperplasia in bile duct-ligated (BDL) rats. We studied whether follicle-stimulating homione (FSH) regulates cholangiocyte proliferation. FSH receptor (FSHR) and FSH expression was evaluated in liver sections, purified cholangiocytes, and cholangiocyte cultures (NRICC). In vivo, normal female and male rats were treated with FSH or immediately after BDL with antide (a gonadotropin-releasing hormone antagonist blocking FSH secretion) or a neutralizing FSH antibody for 1 wk. We evaluated 1) cholangiocyte proliferation in sections and cholangiocytes and 2) changes in secretin-stimulated cAMP (functional index of cholangiocyte growth) levels, and ERK 1/2 and Elk-1 phosphorylation. NRICC were stimulated with FSH before evaluation of proliferation, cAMP/IP<subscript>3</subscript> levels, and ERK 1/2 and Elk-1 phosphorylation. To determine whether FSH regulates cholangiocyte proliferation by an autocrine mechanism, we evaluated the effects of 1) cholangiocyte supernatant (containing FSH) on NRICC proliferation and 2) FSH silencing in NRICC before measuring proliferation and ERK1/2 and Elk-1 phosphorylation. Cholangiocytes and NRICC express FSHR and FSH and secrete FSH. In vivo administration of FSH to normal rats increased, whereas administration of antide and anti-FSH antibody to BDL rats decreased 1) ductal mass and 2) secretin-stimulated cAMP levels, proliferation, and ERK1/2 and Elk-1 phbsphorylation in cholangiocytes compared with controls. In NRICC, FSH increased cholangiocyte proliferation, cAMP levels, and ERK1/2 and Elk-1 phosphorylation. The supematant of cholangiocytes increased NRICC proliferation, inhibited by preincubation with anti-FSH antibody. Silencing of FSH gene decreases cholangiocyte proliferation and ERK1/2 and Elk-1 phosphorylation. Modulation of cholangiocyte FSH expression may be important for the management of cholangiopathies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01931857
Volume :
297
Database :
Complementary Index
Journal :
American Journal of Physiology: Gastrointestinal & Liver Physiology
Publication Type :
Academic Journal
Accession number :
43058804
Full Text :
https://doi.org/10.1152/ajpgi.00025.2009